This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Knowing what to include in a retirement plan at 50 is key to success. Prepare a robust financial strategy for your future.
21,323 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A booming corner of lending shows signs of stress as liquidity tightens and defaults rise, with potential spillovers ...
Jack Schlossberg, JFK’s grandson and Manhattan candidate, says Democrats lost touch with young men and explains why h...
Ford’s 5% yield draws income investors, but the path to EV profitability and a big impairment bill raise questions ab...
Britain’s bond panic currently reshapes how households view cash, debt, and even crypto, as gilt volatility and infla...
Kevin O’Leary’s $4.2 billion Softkey exit in 1999 turned him into a millionaire, but the moment was surprisingly low-...
Japan sees renewed toilet paper stockpiling as global oil-market jitters ripple through households. Officials urge ca...
Mortgage rates jump 6.5% this spring, reshaping affordability for buyers. As lenders adjust, borrowers weigh higher p...
Ethereum sits around $2,170 as the scaling debate intensifies. Analysts warn that a fragmented L2 path and security c...
As defense budgets stabilize and technology explodes, investors are re-pricing defense names. This piece examines why...
Casey’s General Stores posted stronger fuel margins and a growing Rewards base, lifting investor optimism. Analysts c...
Netflix unveils its second price hike in roughly 12 months, signaling pricing power but prompting scrutiny of subscri...